Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,532 | -7,506 | -4,272 | -18,522 | -16,312 |
| Depreciation Amortization | -24 | -17 | -9 | -208 | -202 |
| Other Working Capital | 29 | 155 | 29 | 1,276 | 551 |
| Other Operating Activity | -1,417 | -1,074 | 213 | 6,412 | 7,833 |
| Operating Cash Flow | $-12,944 | $-8,442 | $-4,039 | $-11,041 | $-8,129 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,884 | 6,884 | 4,244 | -22,816 | -20,556 |
| PPE Investments | -53 | -12 | -8 | -41 | -30 |
| Other Investing Activity | 0 | 0 | 0 | 196 | 159 |
| Investing Cash Flow | $13,832 | $6,872 | $4,236 | $-22,661 | $-20,428 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,737 | 1,714 | 706 | 24,841 | 24,841 |
| Financing Cash Flow | $1,737 | $1,714 | $706 | $24,841 | $24,841 |
| Beginning Cash Position | 9,826 | 9,826 | 9,826 | 18,688 | 18,688 |
| End Cash Position | 12,450 | 9,971 | 10,729 | 9,826 | 14,972 |
| Net Cash Flow | $2,624 | $144 | $903 | $-8,862 | $-3,716 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,944 | -8,442 | -4,039 | -11,041 | -8,129 |
| Capital Expenditure | -53 | -12 | -8 | -41 | -30 |
| Free Cash Flow | -12,997 | -8,454 | -4,047 | -11,082 | -8,160 |